友芝友生物-B：公司H股全流通获联交所授出上市批准

Core Viewpoint - The company has received approval from the Stock Exchange for the listing and trading of 68.01 million H-shares, which corresponds to the total number of non-listed shares to be converted and listed [1] Group 1 - The approval date for the listing of H-shares is February 4, 2026 [1] - The total number of H-shares approved for listing is 68.01 million [1]